When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
FOLD - Amicus Therapeutics announces positive 18-month data in Pompe Disease Phase 1/2 study
Amicus Therapeutics Inc.
Amicus Therapeutics (NASDAQ:FOLD) announces positive results from a global Phase 1/2 clinical study (ATB200-02) to investigate AT-GAA in patients with Pompe disease.
More news on: Amicus Therapeutics, Inc., Healthcare stocks news,